{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T12:18:24Z","timestamp":1769602704791,"version":"3.49.0"},"reference-count":14,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,8,11]]},"DOI":"10.7759\/cureus.66653","type":"journal-article","created":{"date-parts":[[2024,8,12]],"date-time":"2024-08-12T02:18:05Z","timestamp":1723429085000},"source":"Crossref","is-referenced-by-count":2,"title":["Characterizing the Links Between Systemic Sclerosis and Breast Cancer"],"prefix":"10.7759","author":[{"given":"Aditya","family":"Dutt","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lauren","family":"Arcinas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Justin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rahila","family":"Shaikh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sejoon","family":"Jun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amritpal","family":"Kooner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dhruv","family":"Gandhi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Conor","family":"Dolehide","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(17)30933-9","article-title":"Systemic sclerosis","volume":"390","author":"Denton CP","year":"2017","unstructured":"Denton CP, Khanna D. Systemic sclerosis. Lancet. 2017, 390:1685-99. 10.1016\/S0140-6736(17)30933-9","journal-title":"Lancet"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1002\/acr.24076","article-title":"Incidence, risk factors, and outcomes of cancer in systemic sclerosis","volume":"72","author":"Morrisroe K","year":"2020","unstructured":"Morrisroe K, Hansen D, Huq M, et al.. Incidence, risk factors, and outcomes of cancer in systemic sclerosis. Arthritis Care Res (Hoboken). 2020, 72:1625-35. 10.1002\/acr.24076","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.3109\/03009742.2011.618145","article-title":"Cancer risk among patients with systemic sclerosis: a nationwide population study in Taiwan","volume":"41","author":"Kuo CF","year":"2012","unstructured":"Kuo CF, Luo SF, Yu KH, et al.. Cancer risk among patients with systemic sclerosis: a nationwide population study in Taiwan. Scand J Rheumatol. 2012, 41:44-9. 10.3109\/03009742.2011.618145","journal-title":"Scand J Rheumatol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-007-0546-9","article-title":"Associations of breast cancer development in patients with systemic sclerosis: an exploratory study","volume":"26","author":"Derk CT","year":"2007","unstructured":"Derk CT. Associations of breast cancer development in patients with systemic sclerosis: an exploratory study. Clin Rheumatol. 2007, 26:1615-9. 10.1007\/s10067-007-0546-9","journal-title":"Clin Rheumatol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbspin.2023.105555","article-title":"Clinical and immunological features of patients with cancer-associated systemic sclerosis: an observational study","volume":"90","author":"Lopez L","year":"2023","unstructured":"Lopez L, Barnetche T, Galli G, et al.. Clinical and immunological features of patients with cancer-associated systemic sclerosis: an observational study. Joint Bone Spine. 2023, 90:105555. 10.1016\/j.jbspin.2023.105555","journal-title":"Joint Bone Spine"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2017.03.012","article-title":"Novel risk factors related to cancer in scleroderma","volume":"16","author":"Bernal-Bello D","year":"2017","unstructured":"Bernal-Bello D, de Tena JG, Guill\u00e9n-Del Castillo A, et al.. Novel risk factors related to cancer in scleroderma. Autoimmun Rev. 2017, 16:461-8. 10.1016\/j.autrev.2017.03.012","journal-title":"Autoimmun Rev"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2022.103167","article-title":"Standardized incidence ratios and risk factors for cancer in patients with systemic sclerosis: data from the Spanish Scleroderma Registry (RESCLE)","volume":"21","author":"Carbonell C","year":"2022","unstructured":"Carbonell C, Marcos M, Guill\u00e9n-Del-Castillo A, et al.. Standardized incidence ratios and risk factors for cancer in patients with systemic sclerosis: data from the Spanish Scleroderma Registry (RESCLE). Autoimmun Rev. 2022, 21:103167. 10.1016\/j.autrev.2022.103167","journal-title":"Autoimmun Rev"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1002\/acr.23505","article-title":"Impact of radiation therapy on scleroderma and cancer outcomes in scleroderma patients with breast cancer","volume":"70","author":"Shah DJ","year":"2018","unstructured":"Shah DJ, Hirpara R, Poelman CL, et al.. Impact of radiation therapy on scleroderma and cancer outcomes in scleroderma patients with breast cancer. Arthritis Care Res (Hoboken). 2018, 70:1517-24. 10.1002\/acr.23505","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-016-3288-8","article-title":"Risk factors for malignancy in systemic sclerosis patients","volume":"35","author":"Ka\u015fifo\u011flu T","year":"2016","unstructured":"Ka\u015fifo\u011flu T, Ya\u015far Bilge \u015e, Y\u0131ld\u0131z F, et al.. Risk factors for malignancy in systemic sclerosis patients. Clin Rheumatol. 2016, 35:1529-33. 10.1007\/s10067-016-3288-8","journal-title":"Clin Rheumatol"},{"key":"ref10","article-title":"Evaluation of cancer-associated myositis and scleroderma autoantibodies in breast cancer patients without rheumatic disease","volume":"35","author":"Shah AA","year":"2017","unstructured":"Shah AA, Rosen A, Hummers LK, et al.. Evaluation of cancer-associated myositis and scleroderma autoantibodies in breast cancer patients without rheumatic disease. Clin Exp Rheumatol. 2017, 35:71.","journal-title":"Clin Exp Rheumatol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1177\/1721727X1100900215","article-title":"Cancer in Italian patients with systemic sclerosis","volume":"9","author":"Belloli L","year":"2011","unstructured":"Belloli L, Carlo-Stella N, Ughi N, et al.. Cancer in Italian patients with systemic sclerosis.  Eur J Inflamm. 2011, 9:199-203. 10.1177\/1721727X1100900215","journal-title":"Eur J Inflamm"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2016.08.059","article-title":"Characteristics and treatment of postirradiation morphea: a retrospective multicenter analysis","volume":"76","author":"Fruchter R","year":"2017","unstructured":"Fruchter R, Kurtzman DJ, Mazori DR, Wright NA, Patel M, Vleugels RA, Femia AN. Characteristics and treatment of postirradiation morphea: a retrospective multicenter analysis. J Am Acad Dermatol. 2017, 76:19-21. 10.1016\/j.jaad.2016.08.059","journal-title":"J Am Acad Dermatol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1002\/art.27549","article-title":"Close temporal relationship between onset of cancer and scleroderma in patients with RNA polymerase I\/III antibodies","volume":"62","author":"Shah AA","year":"2010","unstructured":"Shah AA, Rosen A, Hummers L, Wigley F, Casciola-Rosen L. Close temporal relationship between onset of cancer and scleroderma in patients with RNA polymerase I\/III antibodies. Arthritis Rheum. 2010, 62:2787-95. 10.1002\/art.27549","journal-title":"Arthritis Rheum"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.3892\/ol.2023.14082","article-title":"Clinicopathological prognostic characteristics and long\u2011term outcomes of patients with breast cancer and collagen disorder in comparison to those without collagen disorder","volume":"26","author":"Matsuura K","year":"2023","unstructured":"Matsuura K, Osaki A, Ichinose Y, et al.. Clinicopathological prognostic characteristics and long\u2011term outcomes of patients with breast cancer and collagen disorder in comparison to those without collagen disorder. Oncol Lett. 2023, 26:495. 10.3892\/ol.2023.14082","journal-title":"Oncol Lett"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/267037-characterizing-the-links-between-systemic-sclerosis-and-breast-cancer","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,12]],"date-time":"2024-08-12T02:18:09Z","timestamp":1723429089000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/267037-characterizing-the-links-between-systemic-sclerosis-and-breast-cancer"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,11]]},"references-count":14,"URL":"https:\/\/doi.org\/10.7759\/cureus.66653","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,8,11]]}}}